Title:
IMPLANTABLE NALTREXONE TABLETS
Document Type and Number:
WIPO Patent Application WO/2017/033208
Kind Code:
A3
Abstract:
The invention discloses naltrexone implantable tablets which are devoid of metal salts and corticosteroids, and which provide consistent and controlled amount of naltrexone for 3 months or more; also disclosed is methods of treatment comprising the implants and methods of sterilization of the implants.
Inventors:
SAXENA NAVIN (IN)
SAXENA KUNAL (IN)
SAXENA KUNAL (IN)
Application Number:
PCT/IN2016/050280
Publication Date:
May 04, 2017
Filing Date:
August 23, 2016
Export Citation:
Assignee:
RUSAN PHARMA LTD (IN)
International Classes:
A61K9/22; A61K9/20; A61K9/28; A61P25/30
Foreign References:
| US20090208540A1 | 2009-08-20 | |||
| CN102512399A | 2012-06-27 | |||
| US20130084333A1 | 2013-04-04 | |||
| US7914804B2 | 2011-03-29 | |||
| RU2476209C1 | 2013-02-27 | |||
| US20040254208A1 | 2004-12-16 | |||
| US4874612A | 1989-10-17 |
Other References:
See also references of EP 3340968A4
Attorney, Agent or Firm:
P., Aruna Sree (IN)
Download PDF:
Previous Patent: UNDERGROUND COMMUNICATION SYSTEM
Next Patent: HERBAL COMPOSITION FOR THE TREATMENT OF AGE RELATED MACULAR DISEASES
Next Patent: HERBAL COMPOSITION FOR THE TREATMENT OF AGE RELATED MACULAR DISEASES